Latest Board Appointments News

AssetOwl Limited has appointed new directors and secured a $300,000 loan facility as it undertakes a strategic review to revive shareholder value amid a quiet quarter.

DMC Mining Limited progresses its strategic acquisition of the Firawa and Labé uranium projects in Guinea, while navigating key board appointments and capital raising efforts ahead of ASX re-admission.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Voltaic Strategic Resources reports significant gold and poly-metallic mineralisation at its Kooline and Meekatharra projects, alongside a strategic board restructure and a robust cash position of $5.4 million.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

Group 6 Metals Limited reveals a challenging quarter marked by safety incidents and production setbacks at its Dolphin Tungsten Mine, while initiating a major recapitalisation plan to stabilise finances and leadership.

Andromeda Metals has made significant strides in advancing its Great White Project, progressing funding efforts for Stage 1A+ and securing key operational milestones. The company also bolstered its leadership with new board appointments and received a substantial tax refund, positioning it for a critical investment decision.

Western Yilgarn NL reports encouraging exploration results at its Ida Holmes Project, alongside a successful capital raising and strategic board changes, setting the stage for accelerated development in 2025.

Locksley Resources reports standout assay results from its Mojave Project alongside strategic board appointments and a comprehensive review of its Tottenham Copper Project, setting the stage for accelerated exploration and resource development.

dorsaVi reported a modest 1.9% rise in sales revenue to $330k in Q2 FY25, launched its AI-powered Video AI movement analysis platform, and initiated a blockchain integration partnership to enhance data security.

Race Oncology has advanced its Phase 1 clinical trial for RC220, submitting ethics approvals and bolstering its cash reserves to $18.78 million following a $5.25 million R&D tax incentive.

Norwood Systems has launched its CogVoice OpenSpan platform on Microsoft Azure, deepening global CSP engagements and securing additional funding to support its AI-driven voice technology expansion.